Aspirin desensitization achieved after omalizumab treatment in a patient with aspirin-exacerbated urticaria and respiratory disease

J Investig Allergol Clin Immunol. 2015;25(2):133-5.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Allergic Agents / therapeutic use*
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Anti-Inflammatory Agents, Non-Steroidal / immunology
  • Antibodies, Anti-Idiotypic / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Aspirin / adverse effects*
  • Aspirin / immunology
  • Asthma, Aspirin-Induced / diagnosis
  • Asthma, Aspirin-Induced / drug therapy*
  • Asthma, Aspirin-Induced / immunology
  • Female
  • Humans
  • Immune Tolerance / drug effects*
  • Middle Aged
  • Omalizumab
  • Time Factors
  • Treatment Outcome
  • Urticaria / chemically induced
  • Urticaria / diagnosis
  • Urticaria / drug therapy*
  • Urticaria / immunology

Substances

  • Anti-Allergic Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal, Humanized
  • Omalizumab
  • Aspirin